Back to Editor profile » Dr Richard Walker

Dr Richard Walker

Dr Richard Walker

Founding Editor: Dr Richard F Walker

Dr Richard F Walker has broad experience in the theoretical and practical aspects of aging research derived from key positions in academia and industry. His education includes a BS in pharmacy (Rutgers University), an MS in biochemistry (New Mexico State University) and a PhD in endocrine physiology (Rutgers University). Postdoctoral training in neuroendocrinology and neuropharmacology of aging was received at the Center for the Study of Aging and Human Development, Duke University Medical Center and at the University of California, Berkeley. Dr Walker has held academic positions in Clemson University, Sanders-Brown Research Center on Aging at the University of Kentucky Medical Center, Medical College of Pennsylvania and the University of South Florida College of Medicine. Consistent with a productive record of research as evidenced by extensive peer-reviewed publications, many federal, state, local grants including those from the NIH (NIA), NSF and DoD, as well as accomplishments in teaching and service, he was twice awarded tenure. Dr Walker also held administrative positions at his last institution that included director of research compliance and director of the clinical alliance for research, education and service. While in the pharmaceutical industry, he held a director level position in research and development at SmithKline Beecham, Inc and he currently consults for a number of companies through his own corporation. Dr Walker successfully prepared several investigational new drug applications (IND’s) to the FDA for studying hormone replacement in aging subjects, and with his colleague Dr Barry Bercu, has organized and co-chaired many international symposia on clinical interventions in aging. Consistent with his goal to promote evidence-based approaches to healthy aging, Dr Walker coordinated the development of the Society for Applied Research in Aging (SARA), which was devoted to that purpose. He is now the VP of research & development, ProSoma, LLC, and president, Physicians Regulatory & Scientific Services, Inc.